首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >The Right to Know: A Revised Standard for Reporting Incidental Findings
【2h】

The Right to Know: A Revised Standard for Reporting Incidental Findings

机译:知情权:报告偶然发现的修订标准

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

During the course of biomedical research, researchers sometimes obtain information on participants that is outside the aim of the study but may nonetheless be relevant to the participants. These incidental findings, as they are known, have been the focus of a substantial amount of discussion in the bioethics literature, and a consensus has begun to emerge about what researchers should do in light of the possibility of incidental findings. A consensus, however, is not necessarily correct. In this article, we address the common view that reporting of incidental findings should be based primarily on the possibility of medical benefit, factoring in the findings’ validity, clinical actionability, and significance to health or reproduction. While such medical beneficence should not be discarded, the need to give proper attention to participants’ autonomy, privacy, and interests (especially considering discussion of participants’ right not to know) suggests an alternative standard for when to report incidental findings: even if they are of no direct medical benefit, incidental findings should be reported based on the extent to which the participant can be expected to comprehend the information. We will offer a preliminary defense of this alternative as best respecting participants’ autonomy and privacy and promoting their interests. However, we acknowledge that the standard would face significant practical barriers, and these barriers lead us to propose a metaconsent addendum that would allow subjects to essentially waive the comprehension standard when resource or other constraints make meeting it impracticable.
机译:在生物医学研究过程中,研究人员有时会获得参与者的信息,这些信息超出了研究的目的,但可能与参与者有关。众所周知,这些偶然发现已成为生物伦理学文献中大量讨论的焦点,并且鉴于偶然发现的可能性,研究人员应采取的行动已开始形成共识。但是,达成共识不一定是正确的。在本文中,我们提出了一个普遍的观点,即偶然发现的报告应主要基于医疗收益的可能性,并考虑发现的有效性,临床可操作性以及对健康或生殖的重要性。尽管不应放弃这种医疗福利,但需要适当注意参与者的自主权,隐私和利益(特别是考虑讨论参与者的不知情权),这为何时报告偶然发现提供了另一种标准:即使他们由于没有直接的医疗益处,因此应根据预期参与者了解信息的程度来报告偶然发现。我们将对此选择方案进行初步辩护,以最大程度地尊重参与者的自主权和隐私权并增进他们的利益。但是,我们承认该标准将面临重大的实践障碍,这些障碍使我们提出了一个元同意的附录,该附录将允许受试者在资源或其他限制条件使其无法实现时基本放弃理解标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号